| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―28 |
ABO blood types as a risk factor for severe symptoms of COVID-19 infection |
Hany A. Al-Hussaniy, Karam Turath Tawfeeq, Ali H. Alburghaif |
| 2 |
[GO] |
2025―Oct―28 |
Monitoring of patients with concomitant diseases post coronavirus infection |
Taghreed Altaei, Ali O. Yassen |
| 3 |
[GO] |
2024―Nov―28 |
Serum of Interferon Lambda-1 level as a protein biomarker for the diagnosis of COVID-19 severity |
Shakir Abdulridha Abbas, Hanaa Addai Ali, Rawaa Adday Ali, Muthanna Saleh Mashkur, Mohammed Saeed Salman Hasan, Ayat Saeed Awad, Mohauman Mohammed Al Rufaie |
| 4 |
[GO] |
2023―Dec―16 |
Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients |
Aleksander Michalski, Magdalena Goralczyk, Michal Brzozowski, Jakub Dworzanski, Bartlomiej Drop, Ewa Stepien, Malgorzata Polz-Dacewicz |
| 5 |
[GO] |
2022―Oct―21 |
Pharmacotherapy prescribing pattern and outcome for hospitalized patients with severe and critical COVID-19 |
Hayder Assad |
| 6 |
[GO] |
2021―Dec―21 |
The COVID-19 - related problems encountered by nursing homes in Poland and the steps undertaken to prevent disease spread in the first phase of the epidemic |
Barbara Nieradko-Iwanicka, Janusz Iwanicki, Blazej Dyczewski, Mariola Herbet |
| 7 |
[GO] |
2021―Oct―07 |
Casirivimab and imdevimab as investigational monoclonal antibodies for COVID-19 patients - review of the literature |
Gabriela Reka, Angelika Pawlak, Piotr Machowiec, Marcela Maksymowicz, Halina Piecewicz-Szczesna |
